
Grace Therapeutics Investor Relations Material
Latest events

KOL Event
Grace Therapeutics

Q1 2026
12 Aug, 2025

Q4 2025
23 Jun, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Grace Therapeutics Inc
Access all reports
Acasti Pharma Inc is a biopharmaceutical company focused on developing and commercializing therapies for rare and orphan diseases. The company utilizes proprietary delivery platforms for small molecule drug candidates targeting neurological and cardiovascular conditions. The company is headquartered in Laval, Canada, and its shares are listed on the NASDAQ.
Latest articles
)
The Dilemma That Brought Down Kodak
Kodak helped invent digital photography but failed to embrace it. How the innovator's dilemma turned an icon into its own most famous casualty.
21 Aug 2025
)
Maziar Mike Doustdar: Novo Nordisk's New CEO
A portrait of the pharmaceutical giant's new CEO, who assumes the position at a critical time for the company in its competition with Eli Lilly.
12 Aug 2025
)
Novo Nordisk: Tipping the Scale of Innovation
Taking a look at the company behind Ozempic and Wegovy and diving into their history, business, and the challenges it now faces
8 Aug 2025
Ticker symbol
GRCE
Country
🇺🇸 United States